#Flash: Intranasal Vaccine Phase II Trials In Process
The phase II/III clinical trials of Bharat Biotech's intranasal vaccine are planned to begin this week, with the first dosage expected to be delivered by the end of the week and the phase II leg of the trial expected to be completed next month.

Dr. Krishna Ella said after safety was proven in phase-I trial, the firm is now conducting a heterologous phase-II trial with Covaxin as the first dose and intranasal as second dose in the first cohort, two doses of nasal vaccine in the second cohort, and the first dose of nasal vaccine followed by Covaxin as the second dose in the third cohort. He stated that they will know which combination works best in the trial by next month.

If you find this research insightful, please like, comment and share.

For more information please read here: https://health.economictimes.indiatimes.com/news/pharma/intranasal-vaccine-phase-ii-trials-may-end-next-month-bharat-biotech/86427759
Dr. T●●●●z H●●●●●●i and 4 others like this1 share
Like
Comment
Share